According to the company, the three-year contract, which lasts till Oct 2028 and comes with an option to extend by another two years, covers the supply and delivery of laboratory plastic consumables to several national-level research and clinical institutions.
"The company views this contract as strategically important, strengthening the group's industry position through its selection to supply to a national-level research supply network.
"The multi-year duration enhances the group’s recurring revenue base and earnings visibility, contributing positively to its financial performance in the medium term.
"This strategic award enables us to further demonstrate our commitment to operational excellence and supply chain reliability," says AJJ Healthcare CEO William Ong.
See also: Skylink announces new engineering service contract wins and new property lease signing
Ong was appointed to this role just on Oct 21. He was previously director of strategic procurement at ALPS, Singapore's central procurement agency for public healthcare.
AJJ Medtech was in the news earlier this month for signing an MOU with a China-based company to explore the business of introducing humanoid elderly care robots in Singapore.
AJJ Medtech shares last traded at 0.9 cents on Oct 27.
